- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Seventy Percent of Liver Cancer Cases in the US Could be Prevented
GLI Spearheads Initiative to Double the Five-Year Survival Rate by 2030
Washington, DC — The Global Liver Institute (GLI), along with 33 other leading health and medical organizations, has issued a global call-to-action to increase the five-year survival rate for liver cancer from 18% to 36% by 2030.
Liver cancer is a leading cause of cancer deaths worldwide, accounting for more than 700,000 deaths each year. In the United States this year alone more than 42,000 people will be diagnosed with liver cancer and more than 31,000 people will die from this disease. The National Cancer Institute estimates that there were more than 83,000 people living with liver cancer in the United States in 2016.
To read the full press release click here.
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Nathan Walcker Discusses Value-Based Oncology Care Initiatives at FCS
September 8th 2023Nathan Walcker, CEO at Florida Cancer Specialists & Research Institute (FCS), highlights some of the recent partnerships and initiatives at FCS to improve community-based oncology care from a value-based perspective.
Listen
What We’re Reading: New HPV Screenings; Lung Cancer Pills; Migraine Relief Device
November 9th 2023A study suggests that human papillomavirus (HPV) screenings should be updated due to effective HPV vaccines; a new study shows that osimertinib (Tagrisso, AstraZeneca) reduced both the 5-year risk of recurrent cancer and the risk of death in patients with stage 1B to 3A lung cancer; a new smartphone-controlled technology could help those who suffer from migraines.
Read More
